NCT06710470Active, not recruiting
A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring
Deucravacitinib Pregnancy Study: A Retrospective Observational Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring
Source: ClinicalTrials.gov · Last updated 29 Nov 2024
Brief summary (registry, in English)
This observational study aims to assess pregnancy and infant outcomes among pregnant women with psoriasis who have been exposed to deucravacitinib treatment in the USA.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 833 (estimated)
- First submitted
- 26 Nov 2024
- Start date
- 2 Aug 2024
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- Bristol-Myers Squibb
- Diseases
- Psoriasis
- NCT number
- NCT06710470
What you commit to
- Study type: Observational
- Planned participants: 833
- From 2 Aug 2024 to the primary completion date, 31 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Exposure to any known teratogens from 5 half-lives prior to the estimated date of conception through the end of the relevant exposure window
Who the study is looking for
- Maternal age 15 through 50 years at date of conception
- Start of pregnancy, defined as the estimated date of conception, during the accrual period (09-Sep-2022 through 31-Oct-2026)
- Continuous medical and pharmacy coverage for a minimum of 6 months prior to and including the estimated date of conception
- Presence of psoriasis from 12 months prior to the date of conception through the end of pregnancy
Age in the registry: 15 years to 50 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bristol-Meyers Squibb Coordinator of this site? Confirm its status | Lawrenceville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.